Open AccessPrevention of Relapse in Reflux Esophagitis: A Placebo Controlled Study of Ranitidine 150 mg BID and 300 mg BID
Author(s) -
J Hegarty,
Lars Halvorsen,
Bouke P. C. Hazenberg,
Andrzej Nowak,
C. Smith,
A. B. R. Thomson,
Gaston Vantrappen,
Ceri J Mckenna,
Jane G. Mills
Publication year - 1997
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/1997/954342
Subject(s) - ranitidine , placebo , medicine , esophagitis , gastroenterology , reflux , anesthesia , endoscopy , disease , alternative medicine , pathology
To compare the efficacy and safety of long term use of ranitidine 150 mg bid, 300 mg bid and placebo in prevention of endoscopic and symptomatic relapse of reflux esophagitis in an international, double-blind, placebo controlled, parallel group study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom